DE69113338T2 - Pyranobenzoxadiazolderivate. - Google Patents

Pyranobenzoxadiazolderivate.

Info

Publication number
DE69113338T2
DE69113338T2 DE69113338T DE69113338T DE69113338T2 DE 69113338 T2 DE69113338 T2 DE 69113338T2 DE 69113338 T DE69113338 T DE 69113338T DE 69113338 T DE69113338 T DE 69113338T DE 69113338 T2 DE69113338 T2 DE 69113338T2
Authority
DE
Germany
Prior art keywords
represent
carbon atoms
chem
compounds
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69113338T
Other languages
English (en)
Other versions
DE69113338D1 (de
Inventor
Kiyotomo Seto
Hiroo Matsumoto
Yoshimasa Kamikawaji
Kazuhiko Ohrai
Keisuke Ohdoi
Ryozo Sakoda
Yukinori Masuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Application granted granted Critical
Publication of DE69113338D1 publication Critical patent/DE69113338D1/de
Publication of DE69113338T2 publication Critical patent/DE69113338T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69113338T 1990-07-10 1991-07-10 Pyranobenzoxadiazolderivate. Expired - Fee Related DE69113338T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18252590 1990-07-10
JP3120279A JPH04342591A (ja) 1990-07-10 1991-05-24 ピラノベンゾオキサジアゾール誘導体

Publications (2)

Publication Number Publication Date
DE69113338D1 DE69113338D1 (de) 1995-11-02
DE69113338T2 true DE69113338T2 (de) 1996-03-28

Family

ID=26457891

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69113338T Expired - Fee Related DE69113338T2 (de) 1990-07-10 1991-07-10 Pyranobenzoxadiazolderivate.

Country Status (6)

Country Link
US (1) US5272271A (de)
EP (1) EP0466131B1 (de)
JP (1) JPH04342591A (de)
AT (1) ATE128468T1 (de)
CA (1) CA2046730A1 (de)
DE (1) DE69113338T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0492391A3 (en) * 1990-12-26 1993-01-20 Nissan Chemical Industries Ltd. Hair growth stimulator
JP5523993B2 (ja) * 2010-08-31 2014-06-18 富士フイルム株式会社 酸ハロゲン化物の製造方法、及び酸ハロゲン化物
WO2015063001A1 (en) * 2013-10-29 2015-05-07 F. Hoffmann-La Roche Ag Crystalline forms of a pyrrolidone derivative useful in the treatment of alzheimer's disease and preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033612B1 (de) * 1980-02-02 1984-04-11 Beecham Group Plc Pyranoderivate, Verfahren zu ihrer Herstellung und diese enthaltende antihypertensive Zusammensetzungen
JPH0699439B2 (ja) * 1988-02-03 1994-12-07 日産化学工業株式会社 ピラノベンゾオキサジアゾール誘導体

Also Published As

Publication number Publication date
EP0466131B1 (de) 1995-09-27
CA2046730A1 (en) 1992-01-11
US5272271A (en) 1993-12-21
JPH04342591A (ja) 1992-11-30
ATE128468T1 (de) 1995-10-15
EP0466131A3 (en) 1992-03-04
EP0466131A2 (de) 1992-01-15
DE69113338D1 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
GR3020682T3 (en) Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
MY132263A (en) Pyridazinone derivatives and processes for preparing the same
HUT52521A (en) Process for producing estremustine-esters and pharmaceutical compositions containing them as active components
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
ES8706610A1 (es) Proceso para preparar un derivado de aminoalcohol.
ATE128468T1 (de) Pyranobenzoxadiazolderivate.
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
ES8308554A1 (es) "procedimiento de obtencion de productos para tratamiento de polimeros polihidroxilicos o poliaminicos".
GB2095673B (en) Polymethylene-morpholines
ATE86629T1 (de) 4-piperidincarboxamid-derivate.
DE69327092D1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
AU583267B2 (en) 9-halogen prostane derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee